Search

Joseph J. Kukella

Examiner (ID: 18482, Phone: (571)272-4679 , Office: P/2913 )

Most Active Art Unit
2913
Art Unit(s)
2961, 2913
Total Applications
1553
Issued Applications
1431
Pending Applications
3
Abandoned Applications
119

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19904098 [patent_doc_number] => 12281094 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-22 [patent_title] => Preparation method of racemic nicotine [patent_app_type] => utility [patent_app_number] => 17/547254 [patent_app_country] => US [patent_app_date] => 2021-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17547254 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/547254
Preparation method of racemic nicotine Dec 9, 2021 Issued
Array ( [id] => 18964140 [patent_doc_number] => 11897890 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-13 [patent_title] => 2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof [patent_app_type] => utility [patent_app_number] => 17/547983 [patent_app_country] => US [patent_app_date] => 2021-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 27552 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17547983 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/547983
2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof Dec 9, 2021 Issued
Array ( [id] => 19127131 [patent_doc_number] => 20240132484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-25 [patent_title] => BROAD SPECTRUM ANTIVIRAL COMPOUNDS TARGETING THE SKI COMPLEX [patent_app_type] => utility [patent_app_number] => 18/265191 [patent_app_country] => US [patent_app_date] => 2021-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62083 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265191 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/265191
BROAD SPECTRUM ANTIVIRAL COMPOUNDS TARGETING THE SKI COMPLEX Dec 2, 2021 Pending
Array ( [id] => 18971835 [patent_doc_number] => 20240051927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => FLOW SYNTHESIS OF RDX [patent_app_type] => utility [patent_app_number] => 18/256548 [patent_app_country] => US [patent_app_date] => 2021-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2326 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18256548 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/256548
FLOW SYNTHESIS OF RDX Nov 30, 2021 Pending
Array ( [id] => 18920545 [patent_doc_number] => 20240023549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-25 [patent_title] => FUNGICIDAL ARYL AMIDINES [patent_app_type] => utility [patent_app_number] => 18/253822 [patent_app_country] => US [patent_app_date] => 2021-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17616 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18253822 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/253822
FUNGICIDAL ARYL AMIDINES Nov 21, 2021 Pending
Array ( [id] => 17443634 [patent_doc_number] => 20220064139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => FLUOROLACTONE AND METHOD FOR PRODUCING SAME [patent_app_type] => utility [patent_app_number] => 17/521155 [patent_app_country] => US [patent_app_date] => 2021-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12740 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17521155 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/521155
Fluorolactone and method for producing same Nov 7, 2021 Issued
Array ( [id] => 18223867 [patent_doc_number] => 20230062861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => PPARg MODULATORS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/521666 [patent_app_country] => US [patent_app_date] => 2021-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 184648 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -40 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17521666 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/521666
PPARg MODULATORS AND METHODS OF USE Nov 7, 2021 Pending
Array ( [id] => 17428349 [patent_doc_number] => 20220056057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => Novel Lipids [patent_app_type] => utility [patent_app_number] => 17/520287 [patent_app_country] => US [patent_app_date] => 2021-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21639 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17520287 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/520287
Cardiopathy-reducing phosphodiester lipids Nov 4, 2021 Issued
Array ( [id] => 17426782 [patent_doc_number] => 20220054490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/517620 [patent_app_country] => US [patent_app_date] => 2021-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73005 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17517620 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/517620
Hydantoin derivatives useful as Kv3 inhibitors Nov 1, 2021 Issued
Array ( [id] => 17399485 [patent_doc_number] => 20220041575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-10 [patent_title] => METHODS OF MANUFACTURING OF NIRAPARIB [patent_app_type] => utility [patent_app_number] => 17/452928 [patent_app_country] => US [patent_app_date] => 2021-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20167 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17452928 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/452928
Methods of manufacturing of niraparib Oct 28, 2021 Issued
Array ( [id] => 17399484 [patent_doc_number] => 20220041574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-10 [patent_title] => PYRAZOLE AMINE REACTIVE CRYSTALLIZATION [patent_app_type] => utility [patent_app_number] => 17/505745 [patent_app_country] => US [patent_app_date] => 2021-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6095 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17505745 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/505745
PYRAZOLE AMINE REACTIVE CRYSTALLIZATION Oct 19, 2021 Abandoned
Array ( [id] => 17413954 [patent_doc_number] => 20220048858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides [patent_app_type] => utility [patent_app_number] => 17/506331 [patent_app_country] => US [patent_app_date] => 2021-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 102958 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17506331 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/506331
Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides Oct 19, 2021 Issued
Array ( [id] => 20040799 [patent_doc_number] => 20250179021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-05 [patent_title] => Method For Preparing Meta-Functionalized Pyridine Compound [patent_app_type] => utility [patent_app_number] => 18/038029 [patent_app_country] => US [patent_app_date] => 2021-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 306 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18038029 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/038029
Method for preparing meta-functionalized pyridine compound Oct 14, 2021 Issued
Array ( [id] => 17850455 [patent_doc_number] => 20220280496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR [patent_app_type] => utility [patent_app_number] => 17/500039 [patent_app_country] => US [patent_app_date] => 2021-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20486 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17500039 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/500039
PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR Oct 12, 2021 Abandoned
Array ( [id] => 18808533 [patent_doc_number] => 20230382866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => PROCESS FOR THE PREPARATION OF 5-(1-CYANOCYCLOPROPYL)-PYRIDINE-2-CARBOXYLIC ACID ESTERS AMIDES AND NITRILES [patent_app_type] => utility [patent_app_number] => 18/248289 [patent_app_country] => US [patent_app_date] => 2021-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8608 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248289 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/248289
PROCESS FOR THE PREPARATION OF 5-(1-CYANOCYCLOPROPYL)-PYRIDINE-2-CARBOXYLIC ACID ESTERS AMIDES AND NITRILES Oct 7, 2021 Pending
Array ( [id] => 17704490 [patent_doc_number] => 20220204496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => PROCESS FOR PREPARING 5-[[4-[2-[5-(1-HYDROXYETHYL)-2-PYRIDINYL]ETHOXY]PHENYL]-METHYL]-2,4-THIAZOLIDINEDIONE AND SALTS THEREOF [patent_app_type] => utility [patent_app_number] => 17/479838 [patent_app_country] => US [patent_app_date] => 2021-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19303 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479838 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/479838
Process for preparing 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]-methyl]-2,4-thiazolidinedione and salts thereof Sep 19, 2021 Issued
Array ( [id] => 18980087 [patent_doc_number] => 11905247 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-20 [patent_title] => Compounds as neurokinin-1 receptor antagonists and uses thereof [patent_app_type] => utility [patent_app_number] => 17/476028 [patent_app_country] => US [patent_app_date] => 2021-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 14 [patent_no_of_words] => 22935 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17476028 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/476028
Compounds as neurokinin-1 receptor antagonists and uses thereof Sep 14, 2021 Issued
Array ( [id] => 17720408 [patent_doc_number] => 20220213128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-07 [patent_title] => L-Dopa Enhanced with a Neuroprotective Agent as a Therapy for Parkinson's Disease [patent_app_type] => utility [patent_app_number] => 17/473032 [patent_app_country] => US [patent_app_date] => 2021-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9411 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17473032 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/473032
L-Dopa Enhanced with a Neuroprotective Agent as a Therapy for Parkinson's Disease Sep 12, 2021 Abandoned
Array ( [id] => 18753889 [patent_doc_number] => 20230357212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => THIOPHENOXIME AND FURANOXIME SCAFFOLDS [patent_app_type] => utility [patent_app_number] => 18/044850 [patent_app_country] => US [patent_app_date] => 2021-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11118 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044850 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/044850
THIOPHENOXIME AND FURANOXIME SCAFFOLDS Sep 9, 2021 Pending
Array ( [id] => 17274354 [patent_doc_number] => 20210380552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-09 [patent_title] => APPARATUS FOR CANNABINOL GENERATION AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/411607 [patent_app_country] => US [patent_app_date] => 2021-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39339 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17411607 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/411607
APPARATUS FOR CANNABINOL GENERATION AND METHODS OF USING THE SAME Aug 24, 2021 Abandoned
Menu